Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-09-01
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
PPAR Research has retracted the article titled “Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms” due to figure duplication.
American Psychological Association (APA)
2020. Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms. PPAR Research،Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1206656
Modern Language Association (MLA)
Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms. PPAR Research No. 2020 (2020), pp.1-1.
https://search.emarefa.net/detail/BIM-1206656
American Medical Association (AMA)
Retracted: Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγ Dependent and Independent Mechanisms. PPAR Research. 2020. Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1206656
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1206656
